Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Microbiome Report for the week ending 7-21-18
Microbiome Report for the week ending 7-21-18
Microbiome Report for the week ending 7-21-18
Submitted by
admin
on July 23, 2018 - 4:51pm
Source:
CP Wire
News Tags:
microbiome
UVA
chronic fatigue syndrome
SkinBioTherapeutics
autism
Headline:
Microbiome Report for the week ending 7-21-18
snippet:
SkinBioTherapeutics receives provisional ethics approval for human study
SkinBioTherapeutics plc (AIM: SBTX) announced that it has received provisional ethics approval for its human study scheduled to start later this year.
Do Not Allow Advertisers to Use My Personal information
